Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer

Authors:	Stefanadis Christodoulos Synetos Andreas Tousoulis Dimitris Tsiamis Eleftherios Michelongona Archontoula Zagouri Flora Bamias Aristotle Dimopoulos Meletios Athanasios Kyvelou Stella Kapelakis Ioannis Toutouzas Konstantinos

Affiliation:	^a First Department of Cardiology, Athens Medical School, Athens, Greece ^b Third Department of Medical Oncology, “Agii Anargiri” Hospital, Athens, Greece ^c Department of Therapeutics, “Alexandra” Hospital, Athens Medical School, Athens, Greece ^d First Cardiology Department, Evangelismos Hospital, Athens, Greece

Abstract:

Keywords:	Bevacizumab Neovascularization Systolic dysfunction Vasa vasorum
本文献已被 ScienceDirect PubMed 等数据库收录！